NYSE Regulation fines UBS $49.5 million

LOSSES & LAWSUITS

The regulator said half the penalty would be payable to the State of New Jersey. Of the remaining $24.75 million, $18 million would be placed in a distribution fund to compensate injured customers of UBS who, during the relevant period, invested long-term in the same mutual funds that were the subject of market-timing; a $5.75 million penalty will be paid to the NYSE; and credit was given for $1 million being separately paid to the State of Connecticut as part payment in a matter relating to improper market-timing.

Any remaining amount in the distribution fund after compensating UBS customers will then be distributed to other investors who were not UBS customers but who invested in these affected mutual funds. Any unused portion will revert to NYSE Regulation after three years.

"When a brokerage firm permits a hedge fund or any other market participant to trade deceptively and gain an unfair advantage over other investors, it has violated the trust that forms the foundation of our capital markets," says Richard Ketchum, chief regulatory officer, New York Stock Exchange. "UBS's failure to have adequate controls in place led to this unfortunate occurrence."

"A broker-dealer must respond swiftly and effectively when misconduct is detected that places any of its customers at risk," says Susan Merrill, chief of enforcement, NYSE Regulation. "Our order is focused upon getting money back into the hands of injured investors."

Beginning in January 2000 and continuing through December 2002, brokers in at least seven UBS branch offices engaged in deceptive market-timing to benefit their customers, typically hedge funds, to the detriment of the affected mutual funds and their non-market-timing shareholders. The brokers used deceptive trading practices to conceal their identities, and those of their customers, to enable them to trade in mutual funds that sought to limit or curtail their market-timing.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here